Exagen Inc. (XGN): Shareholders' Equity
$17.45M
As of 2025-12-31
$12.22M
As of 2026-06-30
-25.7%
3-year compound annual growth
-16.0%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.45M | +82.9% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $9.54M | -58.0% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $22.69M | -46.6% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $42.46M | -50.0% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $84.94M | +103.0% | 2023-03-20, Balance as of period end |
| 2020-12-31 | $41.84M | -24.8% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $55.66M | n/m | 2021-03-16, Balance as of period end |
| 2018-12-31 | -$111.97M | n/a | 2020-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Exagen Inc. (XGN) | 2025-12-31 | $17.45M | +82.9% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $261.19M | +28.7% |
| Biodesix Inc (BDSX) | 2025-12-31 | -$2.46M | n/m |
| CapForce Inc. (CFOR) | 2025-12-31 | $31.86M | +331.6% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.58B | +3.0% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.69M | -7.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $480.11M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.11B | -1.9% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $470.87M | +3.3% |
Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗